FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912481806> ?p ?o ?g. }

• W2912481806 endingPage "355" @default.
• W2912481806 startingPage "349" @default.
• W2912481806 abstract "Objectives: To investigate the relationship between the cell percentage of T regulator (Treg) cells of patients’ specimens and disease severity, survivability, recurrence and metastasis in patients who were diagnosed with nasopharyngeal carcinoma (NPC). Design, Setting and Participants: Sixty patients who were diagnosed as NPC and treated by the same protocol were enrolled to the study. Patient files were reviewed retrospectively and their clinical and pathological results were recorded. Deparaffinized samples of nasopharyngeal carcinoma patients were stained immunohistochemically with anti‐FoxP3 monoclonal antibody. All patients’s Anti‐FoxP3 stained slides were evaluated by the same pathologist. Stained Treg lymphocytes around the tumoral foci were investigated. Patients were divided into two groups according to the total anti‐FoxP3‐stained Treg cell counts of the specimens; that is, less than 20% of the total or more than 20% of the total. These groups were compared statistically. Main Outcome Measures: Intensity of FoxP3 which is related to negative tumor response was the main outcome measure. It was evaluated in terms of stage, survival, recurrence and metastasis. Results: The study group consisted of 42 male patients (70%) and 18 female patients (30%). The mean age was 47 ± 14.9. NPC subtypes among the patients were undifferentiated non‐keratinized type in 54 patients (90%), differentiated non‐keratinized type in 4 patients (6.66%) and keratinized type squamous cell carcinoma (SCC) in 2 patients (3.33%). When the two groups were compared in terms of pathological subtype, there was no significant variation between the two groups. There was also no significant variation between the two groups when compared on the basis of tumor stage ( P = 0.36 for T phase, P = 0.122 for N phase), early stage, late phase ( P = 0.15), survival rate ( P = 0.69 for general survival), recurrence ( P = 0.2 for local recurrence, P = 0.37 for regional recurrence) and distant metastasis ( P = 0.3). Conclusion: There was no significant relationship between the concentration of these cells in the stained specimens and the disease stage, survival rate, recurrence and distant metastasis discovered." @default.
• W2912481806 created "2019-02-21" @default.
• W2912481806 creator A5010469345 @default.
• W2912481806 creator A5029668288 @default.
• W2912481806 creator A5045703955 @default.
• W2912481806 creator A5059854078 @default.
• W2912481806 creator A5071764014 @default.
• W2912481806 creator A5078437378 @default.
• W2912481806 creator A5083603553 @default.
• W2912481806 date "2019-03-12" @default.
• W2912481806 modified "2023-10-02" @default.
• W2912481806 title "The effect of FoxP3 on tumour stage, treatment response, recurrence and survivalability in nasopharynx cancer patients" @default.
• W2912481806 cites W1530044612 @default.
• W2912481806 cites W1969762178 @default.
• W2912481806 cites W1981128385 @default.
• W2912481806 cites W1981541211 @default.
• W2912481806 cites W1981989535 @default.
• W2912481806 cites W1996123836 @default.
• W2912481806 cites W2006000411 @default.
• W2912481806 cites W2006864255 @default.
• W2912481806 cites W2034190600 @default.
• W2912481806 cites W2035151186 @default.
• W2912481806 cites W2045019286 @default.
• W2912481806 cites W2045352770 @default.
• W2912481806 cites W2046609236 @default.
• W2912481806 cites W2064810566 @default.
• W2912481806 cites W2067096807 @default.
• W2912481806 cites W2086931150 @default.
• W2912481806 cites W2111247797 @default.
• W2912481806 cites W2116015828 @default.
• W2912481806 cites W2134126186 @default.
• W2912481806 cites W2151444514 @default.
• W2912481806 cites W2157620815 @default.
• W2912481806 cites W2158920133 @default.
• W2912481806 cites W2167523219 @default.
• W2912481806 cites W2304812286 @default.
• W2912481806 cites W2604577110 @default.
• W2912481806 doi "https://doi.org/10.1111/coa.13311" @default.
• W2912481806 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30756505" @default.
• W2912481806 hasPublicationYear "2019" @default.
• W2912481806 type Work @default.
• W2912481806 sameAs 2912481806 @default.
• W2912481806 citedByCount "2" @default.
• W2912481806 countsByYear W29124818062022 @default.
• W2912481806 crossrefType "journal-article" @default.
• W2912481806 hasAuthorship W2912481806A5010469345 @default.
• W2912481806 hasAuthorship W2912481806A5029668288 @default.
• W2912481806 hasAuthorship W2912481806A5045703955 @default.
• W2912481806 hasAuthorship W2912481806A5059854078 @default.
• W2912481806 hasAuthorship W2912481806A5071764014 @default.
• W2912481806 hasAuthorship W2912481806A5078437378 @default.
• W2912481806 hasAuthorship W2912481806A5083603553 @default.
• W2912481806 hasConcept C121608353 @default.
• W2912481806 hasConcept C126322002 @default.
• W2912481806 hasConcept C142724271 @default.
• W2912481806 hasConcept C143998085 @default.
• W2912481806 hasConcept C146357865 @default.
• W2912481806 hasConcept C151730666 @default.
• W2912481806 hasConcept C203014093 @default.
• W2912481806 hasConcept C207886595 @default.
• W2912481806 hasConcept C2777546739 @default.
• W2912481806 hasConcept C2778997737 @default.
• W2912481806 hasConcept C2779013556 @default.
• W2912481806 hasConcept C2779727006 @default.
• W2912481806 hasConcept C509974204 @default.
• W2912481806 hasConcept C71924100 @default.
• W2912481806 hasConcept C86803240 @default.
• W2912481806 hasConcept C8891405 @default.
• W2912481806 hasConcept C90924648 @default.
• W2912481806 hasConceptScore W2912481806C121608353 @default.
• W2912481806 hasConceptScore W2912481806C126322002 @default.
• W2912481806 hasConceptScore W2912481806C142724271 @default.
• W2912481806 hasConceptScore W2912481806C143998085 @default.
• W2912481806 hasConceptScore W2912481806C146357865 @default.
• W2912481806 hasConceptScore W2912481806C151730666 @default.
• W2912481806 hasConceptScore W2912481806C203014093 @default.
• W2912481806 hasConceptScore W2912481806C207886595 @default.
• W2912481806 hasConceptScore W2912481806C2777546739 @default.
• W2912481806 hasConceptScore W2912481806C2778997737 @default.
• W2912481806 hasConceptScore W2912481806C2779013556 @default.
• W2912481806 hasConceptScore W2912481806C2779727006 @default.
• W2912481806 hasConceptScore W2912481806C509974204 @default.
• W2912481806 hasConceptScore W2912481806C71924100 @default.
• W2912481806 hasConceptScore W2912481806C86803240 @default.
• W2912481806 hasConceptScore W2912481806C8891405 @default.
• W2912481806 hasConceptScore W2912481806C90924648 @default.
• W2912481806 hasFunder F4320321688 @default.
• W2912481806 hasIssue "3" @default.
• W2912481806 hasLocation W29124818061 @default.
• W2912481806 hasLocation W29124818062 @default.
• W2912481806 hasOpenAccess W2912481806 @default.
• W2912481806 hasPrimaryLocation W29124818061 @default.
• W2912481806 hasRelatedWork W1987468340 @default.
• W2912481806 hasRelatedWork W2016336310 @default.
• W2912481806 hasRelatedWork W2053546346 @default.
• W2912481806 hasRelatedWork W2157364858 @default.
• W2912481806 hasRelatedWork W2347778667 @default.
• W2912481806 hasRelatedWork W2356105190 @default.

• next